Protein kinase Cα-induced derepression of the human luteinizing hormone receptor gene transcription through ERK-mediated release of HDAC1/Sin3A repressor complex from Sp1 sites

Molecular Endocrinology

Volumn 22, Issue 6, 2008, Pages 1449-1463

  Liao, Mingjuan ^a   Zhang, Ying ^a   Dufau, Maria L ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 1; HISTONE H3; LUTEINIZING HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C ALPHA; RNA POLYMERASE II; SERINE; TRANSCRIPTION FACTOR IIB; TRANSCRIPTION FACTOR SIN3A; TRANSCRIPTION FACTOR SP1; HDAC1 PROTEIN, HUMAN; HISTONE DEACETYLASE; MULTIPROTEIN COMPLEX; REPRESSOR PROTEIN; SIN3A TRANSCRIPTION FACTOR;

ACETYLATION; AMINO ACID SEQUENCE; ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DISSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; GENE ACTIVATION; GENE ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RECEPTOR GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; BINDING SITE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN BINDING; TUMOR CELL CULTURE;

BINDING SITES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HELA CELLS; HISTONE DEACETYLASE 1; HISTONE DEACETYLASES; HUMANS; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN KINASE C-ALPHA; RECEPTORS, LH; REPRESSOR PROTEINS; SP1 TRANSCRIPTION FACTOR; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 44649166455     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0035     Document Type: Article

References (68)

1. Dufau ML, Tsai-Morris C-H 2007 The Leydig cell in health and disease. In: Payne AH, Hardy MP, eds. Contemporary endocrinology. Totowa, NJ: Humana Press Inc.; 227-252
2. Dufau ML 1998 The luteinizing hormone receptor. Annu Rev Physiol 60:461-496
3. Tsai-Morris C, Xie X, Wang W, Buczko E, Dufau M 1993 Promoter and regulatory regions of the rat luteinizing hormone receptor gene. J Biol Chem 268:4447-4452
4. Tsai-Morris C, Geng Y, Xie X, Buczko E, Dufau M 1994 Transcriptional protein binding domains governing basal expression of the rat luteinizing hormone receptor gene. J Biol Chem 269:15868-15875
5. Tsai-Morris CH, Geng Y, Buczko E, Dufau ML 1998 A novel human luteinizing hormone receptor gene. J Clin Endocrinol Metab 83:288-293
6. Zhang Y, Dufau ML 2000 Nuclear orphan receptors regulate transcription of the gene for the human luteinizing hormone receptor. J Biol Chem 275:2763-2770
7. Zhang Y, Dufau ML 2001 EAR2 and EAR3/COUP-TFI regulate transcription of the rat LH receptor. Mol Endocrinol 15:1891-1905
8. Zhang Y, Dufau ML 2003 Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB. Mol Cell Biol 23:6958-6972
9. Zhang Y, Dufau ML 2002 Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. J Biol Chem 277:33431-33438
10. Zhang Y, Fatima N, Dufau ML 2005 Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Mol Cell Biol 25:7929-7939
11. Zhang Y, Liao M, Dufau ML 2006 Phosphatidylinositol 3-kinase/protein kinase Cζ-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated depression of transcription of the luteinizing hormone receptor gene. Mol Cell Biol 26:6748-6761
12. Chu S, Ferro TJ 2005 Sp1: Regulation of gene expression by phosphorylation. Gene 348:1-11
13. Milanini-Mongiat J, Pouyssegur J, Pages G 2002 Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277:20631-20639
14. Fojas de Borja P, Collins NK, Du P, Azizkhan-Clifford J, Mudryj M 2001 Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J 20:5737-5747
15. Parker PJ, Murray-Rust J 2004 PKC at a glance. J Cell Sci 117:131-132
16. Newton AC 1995 Protein kinase C: structure, function, and regulation. J Biol Chem 270:28495-28498
17. Teicher BA 2006 Protein kinase C as a therapeutic target. Clin Cancer Res 12:5336-5345
18. Noland Jr T, Dimino M 1986 Characterization and distribution of protein kinase C in ovarian tissue. Biol Reprod 35:863-872
19. Clark MR, Davis JS, Lemaire WJ 1983 Calcium- and lipid-dependent protein phosphorylation in the human ovary. J Clin Endocrinol Metab 57:872-874
20. Davis JS, Clark MR 1983 Activation of protein kinase in the bovine corpus luteum by phospholipid and Ca2+. Biochem J 214:569-574
21. Shimamoto T, Yamoto M, Nakano R 1993 Possible involvement of protein kinase C in gonadotropin-induced ovulation in the rat ovary. Endocrinology 133:2127-2132
22. Cutler Jr RE, Maizels ET, Brooks EJ, Mizuno K, Ohno S, Hunzicker-Dunn M 1993 Regulation of δ protein kinase C during rat ovarian differentiation. Biochim Biophys Acta 1179:260-270
23. Braden TD, Bervig T, Conn PM 1991 Protein kinase-C activation stimulates synthesis of gonadotropin-releasing hormone (GnRH) receptors, but does not mediate GnRH-stimulated receptor synthesis. Endocrinology 129:2486-2490
24. Anderson L 1996 Intracellular mechanisms triggering gonadotrophin secretion. Rev Reprod 1:193-202
25. Vasilyev VV, Lawson MA, Dipaolo D, Webster NJ, Mellon PL 2002 Different signaling pathways control acute induction versus long-term repression of LHβ transcription by GnRH. Endocrinology 143:3414-3426
26. Leung P, Steele G 1992 Intracellular signaling in the gonads. Endocr Rev 13:476-498
27. Pati D, Habibi HR 2002 Involvement of protein kinase C and arachidonic acid pathways in the gonadotropin-releasing hormone regulation of oocyte meiosis and follicular steroidogenesis in the goldfish ovary. Biol Reprod 66:813-822
28. Cheng KW, Ngan ESW, Kang SK, Chow BKC, Leung PCK 2000 Transcriptional down-regulation of human gonadotropin-releasing hormone (GnRH) receptor gene by GnRH: role of protein kinase C and activating protein 1. Endocrinology 141:3611-3622
29. Yeung C-M, An B-S, Cheng CK, Chow BKC, Leung PCK 2005 Expression and transcriptional regulation of the GnRH receptor gene in human neuronal cells. Mol Hum Reprod 11:837-842
30. Lin X, Conn PM 1999 Transcriptional activation of gonadotropin-releasing hormone (GnRH) receptor gene by GnRH: involvement of multiple signal transduction pathways. Endocrinology 140:358-364
31. Geng Y, Tsai-Morris CH, Zhang Y, Dufau ML 1999 The human luteinizing hormone receptor gene promoter: activation by Sp1 and Sp3 and inhibitory regulation. Biochem Biophys Res Commun 263:366-371
32. Chun RF, Semmes OJ, Neuveut C, Jeang K-T 1998 Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J Virol 72:2615-2629
33. Schonwasser DC, Marais RM, Marshall CJ, Parker PJ 1998 Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 18:790-798
34. Nakashima S 2002 Protein kinase Cα: regulation and biological function. J Biochem (Tokyo) 132:669-675
35. Marais R, Wynne J, Treisman R 1993 The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393
36. Gille H, Sharrocks AD, Shaw PE 1992 Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358:414-417
37. Soh J-W, Lee EH, Prywes R, Weinstein IB 1999 Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Mol Cell Biol 19:1313-1324
38. Kang-Park S, Lee JH, Shin JH, Lee YI 2001 Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings. Biochem Biophys Res Commun 283:303-307
39. Pintus G, Tadolini B, Posadino AM, Sanna B, Debidda M, Carru C, Deiana L, Ventura C 2003 PKC/Raf/MEK/ERK signaling pathway modulates native-LDL-induced E2F-1 gene expression and endothelial cell proliferation. Cardiovasc Res 59:934-944
40. Lindemann RK, Braig M, Hauser CA, Nordheim A, Dittmer J 2003 Ets2 and protein kinase C ε are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells. Biochem J 372:787-797
41. Soh JW, Lee YS, Weinstein IB 2003 Effects of regulatory domains of specific isoforms of protein kinase C on growth control and apoptosis in MCF-7 breast cancer cells. J Exp Ther Oncol 3:115-126
42. Biggs JR, Kudlow JE, Kraft AS 1996 The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J Biol Chem 271:901-906
43. Han JW, Ahn SH, Kim YK, Bae GU, Yoon JW, Hong S, Lee HY, Lee YW, Lee HW 2001 Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: involvement of protein kinase C. J Biol Chem 276:42084-42090
44. Hu PP-c, Shen X, Huang D, Liu Y, Counter C, Wang X-F 1999 The MEK pathway is required for stimulation of p21WAF1/CIP1 by transforming growth factor-β. J Biol Chem 274:35381-35387
45. Huang L, Sowa Y, Sakai T, Pardee AB 2000 Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Oncogene 19:5712-5719
46. Sowa Y, Orita T, Minamikawa-Hiranabe S, Mizuno T, Nomura H, Sakai T 1999 Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res 59:4266-4270
47. Wen-Sheng W 2003 ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Oncogene 22:955-963
48. Wen-Sheng W, Jun-Ming H 2005 Activation of protein kinase C α is required for TPA-triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2. J Biomed Sci 12:289-296
49. Gruber JR, Desai S, Blusztajn JK, Niles RM 1995 Retinoic acid specifically increases nuclear PKC α and stimulates AP-1 transcriptional activity in B16 mouse melanoma cells. Exp Cell Res 221:377-384
50. Martelli AM, Evangelisti C, Nyakern M, Manzoli FA 2006 Nuclear protein kinase C. Biochim Biophys Acta 1761:542-551
51. Pan M-R, Hung W-C 2002 Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription. J Biol Chem 277:32775-32780
52. Jackson SP, MacDonald JJ, Lees-Miller S, Tjian R 1990 GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 63:155-165
53. Suzuki T, Kimura A, Nagai R, Horikoshi M 2000 Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding. Genes Cells 5:29-41
54. Emili A, Greenblatt J, Ingles CJ 1994 Species-specific interaction of the glutamine-rich activation domains of Sp1 with the TATA box-binding protein. Mol Cell Biol 14:1582-1593
55. Datta P, Raychaudhuri P, Bagchi S 1995 Association of p107 with Sp1: genetically separable regions of p107 are involved in regulation of E2F- and Sp1-dependent transcription. Mol Cell Biol 15:5444-5452
56. Seto E, Lewist B, Shenk T 1993 Interaction between transcription factors Spl and YY1. Nature 365:462-464
57. Lin S, Black A, Kostic D, Pajovic S, Hoover C, Azizkhan J 1996 Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol Cell Biol 16:1668-1675
58. Lee D-K, Suh D, Edenberg HJ, Hur M-W 2002 POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1. J Biol Chem 277:26761-26768
59. Doetzlhofer A, Rotheneder H, Lagger G, Koranda M, Kurtev V, Brosch G, Wintersberger E, Seiser C 1999 Histone deacetylase 1 can repress transcription by binding to Sp1. Mol Cell Biol 19:5504-5511
60. Kaczynski J, Cook T, Urrutia R 2003 Sp1- and Kruppel-like transcription factors. Genome Biol 4:206
61. Lee J-A, Suh D-C, Kang J-E, Kim M-H, Park H, Lee M-N, Kim J-M, Jeon B-N, Roh H-E, Yu M-Y, Choi K-Y, Kim KY, Hur M-W 2005 Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK. J Biol Chem 280:28061-28071
62. Choi HS, Lee JH, Park JG, Lee YI 2002 Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. Biochem Biophys Res Commun 296:1005-1012
63. Ellenrieder V, Zhang JS, Kaczynski J, Urrutia R 2002 Signaling disrupts mSin3A binding to the Mad1-like Sin3-interacting domain of TIEG2, an Sp1-like repressor. EMBO J 21:2451-2460
64. Galasinski SC, Resing KA, Goodrich JA, Ahn NG 2002 Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J Biol Chem 277:19618-19626
65. Hsieh M, Conti M 2005 G-protein-coupled receptor signaling and the EGF network in endocrine systems. Trends Endocrinol Metab 16:320-326
66. Park JY, Su YQ, Ariga M, Law E, Jin SL, Conti M 2004 EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 303:682-684
67. Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A 1999 Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 341:1731-1736
68. Ujhazy P, Klobusicka M, Babusikova O, Strausbauch P, Mihich E, Ehrke MJ 1994 Ecto-5′-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin. Int J Cancer 59:83-93